Jonas Boström
Jonas Boström
Medicinal Chemistry, AstraZeneca, Sweden
Bestätigte E-Mail-Adresse bei astrazeneca.com
Titel
Zitiert von
Zitiert von
Jahr
Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone? Miniperspective
DG Brown, J Bostrom
Journal of medicinal chemistry 59 (10), 4443-4458, 2016
6322016
Oxadiazoles in medicinal chemistry
J Boström, A Hogner, A Llinàs, E Wellner, AT Plowright
Journal of medicinal chemistry 55 (5), 1817-1830, 2012
4152012
Assessing the performance of OMEGA with respect to retrieving bioactive conformations
J Boström, JR Greenwood, J Gottfries
Journal of Molecular Graphics and Modelling 21 (5), 449-462, 2003
3342003
Conformational energy penalties of protein-bound ligands
J Boström, PO Norrby, T Liljefors
Journal of computer-aided molecular design 12 (4), 383-383, 1998
2701998
Reproducing the conformations of protein-bound ligands: a critical evaluation of several popular conformational searching tools
J Boström
Journal of Computer-Aided Molecular Design 15 (12), 1137-1152, 2001
1922001
Expanding the medicinal chemistry synthetic toolbox
J Boström, DG Brown, RJ Young, GM Keserü
Nature Reviews Drug Discovery 17 (10), 709-727, 2018
1812018
Do structurally similar ligands bind in a similar fashion?
J Boström, A Hogner, S Schmitt
Journal of medicinal chemistry 49 (23), 6716-6725, 2006
1732006
Computational chemistry-driven decision making in lead generation
V Schnecke, J Boström
Drug discovery today 11 (1-2), 43-50, 2006
892006
Molecular rift: virtual reality for drug designers
M Norrby, C Grebner, J Eriksson, J Bostrom
Journal of chemical information and modeling 55 (11), 2475-2484, 2015
782015
Scaffold hopping, synthesis and structure–activity relationships of 5, 6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists
J Boström, K Berggren, T Elebring, PJ Greasley, M Wilstermann
Bioorganic & medicinal chemistry 15 (12), 4077-4084, 2007
612007
Where do recent small molecule clinical development candidates come from?
DG Brown, J Boström
Journal of medicinal chemistry 61 (21), 9442-9468, 2018
602018
A 3D QSAR study on a set of dopamine D4 receptor antagonists
J Boström, M Böhm, K Gundertofte, G Klebe
Journal of chemical information and computer sciences 43 (3), 1020-1027, 2003
542003
Using matched molecular series as a predictive tool to optimize biological activity
NM O’Boyle, J Boström, RA Sayle, A Gill
Journal of medicinal chemistry 57 (6), 2704-2713, 2014
512014
Benzothiazepine derivatives
I Starke, MUJ Dahlstrom, D Blomberg, S Alenfalk, P Nordberg, ...
US Patent 7,192,946, 2007
452007
Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
I Starke, MUJ Dahlstrom, MP Nordberg, S Alenfalk, AC Wallberg, ...
US Patent 7,238,684, 2007
412007
Benzothiazepine derivatives
I Starke, S Alenfalk, MP Nordberg, MUJ Dahlstrom, SJ Bostrom, ...
US Patent 8,067,584, 2011
382011
Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design
N Ståhl, G Falkman, A Karlsson, G Mathiason, J Bostrom
Journal of chemical information and modeling 59 (7), 3166-3176, 2019
372019
Understanding Our Love Affair with p-Chlorophenyl: Present Day Implications from Historical Biases of Reagent Selection
DG Brown, MM Gagnon, J Bostrom
Journal of medicinal chemistry 58 (5), 2390-2405, 2015
352015
Synthesis, structure–property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor
P Bach, J Boström, K Brickmann, JJJ Van Giezen, RD Groneberg, ...
European journal of medicinal chemistry 65, 360-375, 2013
342013
MIMUMBA revisited: Torsion angle rules for conformer generation derived from X-ray structures
J Sadowski, J Boström
Journal of chemical information and modeling 46 (6), 2305-2309, 2006
342006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20